Brief: Promore Pharma Q3 operating loss widens to SEK 4.4 million
Nov 21 (Reuters) - PROMORE PHARMA AB PROMO.ST
* JULY TO SEPTEMBER OPERATING LOSS SEK 4.4 MILLION VERSUS
LOSS
SEK 1.8 MILLION YEAR AGO
Source text for Eikon: ID:nWkr8b7ljT
Further company coverage: PROMO.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PMD Device Solutions AB
See all newsBrief: PMD Device Solutions Files For Bankruptcy
Brief: PMD Device Solutions Q3 EBITDA Loss Widens To SEK 8.9 Mln
Brief: Pmd Device Solutions Completes Sale Of Coala Life Monitor
Brief: PMDS’ Largest Shareholder Requests EGM To Appoint New Non-Executive Directors
Brief: PMDS Says RespiraSense Technology Demonstrates Capability In Predicting 7-Day Mortality